116 related articles for article (PubMed ID: 37137344)
61. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
Zheng D; Lai G; Chen Y; Yue Q; Liu X; Chen X; Chen W; Chan Q; Chen Y
J Magn Reson Imaging; 2018 Nov; 48(5):1208-1216. PubMed ID: 29693765
[TBL] [Abstract][Full Text] [Related]
62. Comparison of Abbreviated MRI and Full Diagnostic MRI in Distinguishing between Benign and Malignant Lesions Detected by Breast MRI: A Multireader Study.
Kim ES; Cho N; Kim SY; Kwon BR; Yi A; Ha SM; Lee SH; Chang JM; Moon WK
Korean J Radiol; 2021 Mar; 22(3):297-307. PubMed ID: 33289355
[TBL] [Abstract][Full Text] [Related]
63. Comparison of the diagnostic performance of abbreviated MRI and full diagnostic MRI using a computer-aided diagnosis (CAD) system in patients with a personal history of breast cancer: the effect of CAD-generated kinetic features on reader performance.
Ha T; Jung Y; Kim JY; Park SY; Kang DK; Kim TH
Clin Radiol; 2019 Oct; 74(10):817.e15-817.e21. PubMed ID: 31362885
[TBL] [Abstract][Full Text] [Related]
64. Breast-Specific Gamma Imaging Versus MRI: Comparing the Diagnostic Performance in Assessing Treatment Response After Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Kim S; Plemmons J; Hoang K; Chaudhuri D; Kelley A; Cunningham T; Hoefer R
AJR Am J Roentgenol; 2019 Mar; 212(3):696-705. PubMed ID: 30620672
[TBL] [Abstract][Full Text] [Related]
65. Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era.
Byon JH; Park YV; Yoon JH; Moon HJ; Kim EK; Kim MJ; You JK
Radiology; 2021 Jul; 300(1):46-54. PubMed ID: 33904772
[TBL] [Abstract][Full Text] [Related]
66. Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.
Kim Y; Sim SH; Park B; Lee KS; Chae IH; Park IH; Kwon Y; Jung SY; Lee S; Ko K; Kang HS; Lee CW; Lee ES
Clin Breast Cancer; 2018 Dec; 18(6):459-467.e1. PubMed ID: 29954674
[TBL] [Abstract][Full Text] [Related]
67. The accuracy of breast MRI radiomic methodologies in predicting pathological complete response to neoadjuvant chemotherapy: A systematic review and network meta-analysis.
O'Donnell JPM; Gasior SA; Davey MG; O'Malley E; Lowery AJ; McGarry J; O'Connell AM; Kerin MJ; McCarthy P
Eur J Radiol; 2022 Dec; 157():110561. PubMed ID: 36308849
[TBL] [Abstract][Full Text] [Related]
68. Predictive Clinicopathologic and Dynamic Contrast-Enhanced MRI Findings for Tumor Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Eom HJ; Cha JH; Choi WJ; Chae EY; Shin HJ; Kim HH
AJR Am J Roentgenol; 2017 Jun; 208(6):W225-W230. PubMed ID: 28350486
[TBL] [Abstract][Full Text] [Related]
69. Abbreviated breast magnetic resonance protocol: Value of high-resolution temporal dynamic sequence to improve lesion characterization.
Oldrini G; Fedida B; Poujol J; Felblinger J; Trop I; Henrot P; Darai E; Thomassin-Naggara I
Eur J Radiol; 2017 Oct; 95():177-185. PubMed ID: 28987664
[TBL] [Abstract][Full Text] [Related]
70. Ultrafast dynamic contrast-enhanced breast MRI: association with pathologic complete response in neoadjuvant treatment of breast cancer.
Kim JH; Park VY; Shin HJ; Kim MJ; Yoon JH
Eur Radiol; 2022 Jul; 32(7):4823-4833. PubMed ID: 35064805
[TBL] [Abstract][Full Text] [Related]
71. Multireader Study on the Diagnostic Accuracy of Ultrafast Breast Magnetic Resonance Imaging for Breast Cancer Screening.
van Zelst JCM; Vreemann S; Witt HJ; Gubern-Merida A; Dorrius MD; Duvivier K; Lardenoije-Broker S; Lobbes MBI; Loo C; Veldhuis W; Veltman J; Drieling D; Karssemeijer N; Mann RM
Invest Radiol; 2018 Oct; 53(10):579-586. PubMed ID: 29944483
[TBL] [Abstract][Full Text] [Related]
72. Noncontrast Breast MRI During Pregnancy Using Diffusion Tensor Imaging: A Feasibility Study.
Nissan N; Furman-Haran E; Allweis T; Menes T; Golan O; Kent V; Barsuk D; Paluch-Shimon S; Haas I; Brodsky M; Bordsky A; Granot LF; Halshtok-Neiman O; Faermann R; Shalmon A; Gotlieb M; Konen E; Sklair-Levy M
J Magn Reson Imaging; 2019 Feb; 49(2):508-517. PubMed ID: 30168650
[TBL] [Abstract][Full Text] [Related]
73. Fast MRI breast cancer screening - Ready for prime time.
Partovi S; Sin D; Lu Z; Sieck L; Marshall H; Pham R; Plecha D
Clin Imaging; 2020 Apr; 60(2):160-168. PubMed ID: 31927171
[TBL] [Abstract][Full Text] [Related]
74. Usefulness of automated breast volume scanner (ABVS) for monitoring tumor response to neoadjuvant treatment in breast cancer patients: preliminary results.
D'Angelo A; Rinaldi P; Belli P; D'Amico R; Carlino G; Grippo C; Giuliani M; Orlandi A; Infante A; Manfredi R
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):225-231. PubMed ID: 30657564
[TBL] [Abstract][Full Text] [Related]
75. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.
Akazawa K; Tamaki Y; Taguchi T; Tanji Y; Miyoshi Y; Kim SJ; Ueda S; Yanagisawa T; Sato Y; Tamura S; Noguchi S
Breast J; 2006; 12(2):130-7. PubMed ID: 16509837
[TBL] [Abstract][Full Text] [Related]
76. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
77. Comparison of the diagnostic performance of response evaluation criteria in solid tumor 1.0 with response evaluation criteria in solid tumor 1.1 on MRI in advanced breast cancer response evaluation to neoadjuvant chemotherapy.
Jeh SK; Kim SH; Kang BJ
Korean J Radiol; 2013; 14(1):13-20. PubMed ID: 23323026
[TBL] [Abstract][Full Text] [Related]
78. Influence of different post-contrast time points on dynamic contrast-enhanced (DCE) MRI T staging in breast cancer.
Romeo V; Picariello V; Pignata A; Mancusi V; Stanzione A; Cuocolo R; Di Crescenzo R; Accurso A; Staibano S; Imbriaco M
Eur J Radiol; 2020 Mar; 124():108819. PubMed ID: 31958631
[TBL] [Abstract][Full Text] [Related]
79. MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
Scheel JR; Kim E; Partridge SC; Lehman CD; Rosen MA; Bernreuter WK; Pisano ED; Marques HS; Morris EA; Weatherall PT; Polin SM; Newstead GM; Esserman LJ; Schnall MD; Hylton NM;
AJR Am J Roentgenol; 2018 Jun; 210(6):1376-1385. PubMed ID: 29708782
[TBL] [Abstract][Full Text] [Related]
80. Magnetic resonance imaging enhancement features before and after neoadjuvant chemotherapy in patients with breast cancer: a predictive value for responders.
Kang DK; Kim TH; Han TS; Kim KS; Yim H
J Comput Assist Tomogr; 2013; 37(3):432-9. PubMed ID: 23674017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
